The global Near Infrared Imaging/NIR market gathered revenue around USD 1.0 Billion in 2020 and market is set to grow USD 2.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 15.0% during the prediction period 2021 to 2027.
Overview of Near Infrared Imaging/NIR Market Study
Near Infrared Imaging/NIR market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.
Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/4358
The growing number of surgical procedures performed globally, advantages of NIR imaging over conventional visualization methods, and technological advancements in NIR imaging modalities. However, the lengthy approval process, which limits the availability of targeted fluorophores, is expected to restrain market growth to a certain extent during the forecast period.
Near-infrared imaging Market Dynamics
Driver: Growing number of surgical procedures globally
Globally, the number of surgical procedures is on the rise owing to the rising prevalence and incidence of various diseases such as cancer, cardiovascular diseases, neurovascular diseases, and gastrointestinal diseases. Surgical cosmetic procedures and trauma cases are also contributing to the increasing number of surgical procedures. NIR imaging is used for intraoperative imaging during various surgical procedures, such as plastic and reconstructive surgeries, oncology surgeries, gastrointestinal surgeries, cardiovascular surgeries, cardiothoracic surgeries, and neurovascular surgeries. NIR imaging enables surgeons to assess blood flow, tissue viability, and perfusion during these surgeries. In cancer surgeries, NIR imaging is used to establish positive margins that help in the demarcation of cancerous tissues versus normal tissues. Therefore, the increasing number of surgical procedures is expected to drive the NIR imaging market.
Restraints: Lengthy approval process
There are only two FDA-approved NIR fluorophores—indocyanine green (ICG) (approved for clinical use in 1959) and methylene blue (MB). However, both ICG and MB are blood pool agents that have no specificity for tumors or normal tissues and are, thus, not ideal fluorophores for fluorescence image-guided surgery. The visualization of the target tissues mainly depends on the efficacy of fluorescent agents, resulting from the difference in the amount of molecular uptake into the target and neighboring normal tissues. Targeted fluorophores enable the visualization of the desired target tissues, thus enhancing the clinical outcomes. However, the introduction of targeted fluorophores is mainly restricted due to the absence of US Food and Drug Administration (FDA) approvals. Additionally, imaging agents have to undergo the same FDA approval process as other pharmaceutical drugs, which may take approximately a decade and around USD 150 million for a fluorescent probe to become available in the market. Post-approval, imaging agents are required to be paired with a specific model of an imaging device. For instance, the approval of Cysview (Photocure) with KARL STORZ’s blue light cystoscope PDD System. This practice limits the entry and adoption of molecularly targeted NIRF imaging agents in clinical practices, thus hindering the market growth.
Opportunities: Growth potential in emerging countries
Developing economies such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa offer high-growth opportunities for major players in the NIR imaging market. Although the cost factor is a concern in these developing countries, their huge population base—especially in India and China—offers a sustainable market for imaging devices. More than half the world’s population resides in India and China, owing to which these countries are home to a large patient base. According to GLOBOCAN 2018, 8,750,932 cancer cases were reported in Asia. Rapid economic growth and increasing disposable incomes in emerging markets are also encouraging patients in these countries to spend on quality healthcare services, thereby encouraging players in the NIR imaging market to expand their presence in these emerging markets. In addition to the above factors, regulatory policies in the Asia Pacific are more adaptive and business-friendly. Increasing competition in mature markets is further expected to compel imaging system manufacturers to focus on emerging markets. Cost advantages and the availability of skilled researchers, coupled with the growth in the number of research institutions, are responsible for the significant growth in the life sciences research industry in these countries. With the growth in the life sciences research industry, the demand for various imaging modalities, including NIR imaging, has increased.
Challenges: Dearth of trained professionals
NIR imaging is a specialized imaging technique and needs skilled operators for its effective utilization. At present, there is a scarcity of skilled operators, especially in developing countries, which is a major factor limiting the uptake of these systems for clinical applications. In addition to this, the technological landscape of the NIR market is constantly evolving, with a growing number of advanced products being launched every year. At present, apart from systems for open surgery, NIR fluorescence imaging is also available for laparoscopic, thoracoscopic, and robot-assisted surgeries. This compels physicians and other healthcare providers to acquire the necessary skills to operate these advanced NIR imaging devices effectively. Owing to this, physicians and healthcare providers are refraining from adopting these imaging systems, which challenges market growth. However, companies such as Carl Zeiss are carrying out various workshops and training sessions on intraoperative fluorescence. These companies present clinical cases in combination with live surgeries to enhance the understanding of the technology and usage of these devices. Such efforts by manufacturers may serve to overcome this challenge in the future.
The near-infrared imaging devices is estimated to account for the largest share of the global near-infrared imaging market during the forecast period.
On the basis of product, devices and probe/dye. The devices product segment, by type, is further segmented into near-infrared fluorescence imaging systems and near-infrared fluorescence and bioluminescence imaging systems. The near-infrared fluorescence imaging systems segment is estimated to account for the largest share of the near-infrared imaging market, by product, in 2021, driven by growing research activities, advantages offered by near-infrared fluorescence imaging systems such as high sensitivity, high image resolution, and real-time image guidance during surgeries, the rising prevalence of cancer, cardiovascular diseases, and gastrointestinal diseases.
The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging market during the forecast period.
On the basis of application, the near-infrared imaging market is segmented into preclinical imaging, clinical imaging, medical imaging. The preclinical imaging segment is estimated to account for the largest share of the global near-infrared imaging market, by application, in 2021, led by The growing focus on developing new treatments for diseases/conditions such as cancer, inflammation, angiogenesis, infections, and vascular diseases.
The hospitals and clinics segment is expected to grow at the highest CAGR during the forecast period.
Based on end-user, the near-infrared imaging market has been segmented into hospitals & clinics, pharmaceutical and biotechnology companies, and research laboratories. As of 2020, hospitals & clinics are estimated to account for the largest share of the global near-infrared imaging market in 2021 and is also projected to register the highest CAGR during the forecast period. The increasing clinical applications of NIR imaging in various therapeutic areas, the growing demand for NIR imaging among clinicians across the globe, and the high sensitivity, high resolution, and low cost of NIR imaging systems compared to conventional imaging systems such as CT and MRI are the major factors that are expected to drive the growth of this end-user segment in the coming years.
North America is expected to be the largest market during the forecast period.
North America accounted for the largest market share in the near-infrared imaging market in 2020. The near-infrared imaging market in North America is driven primarily by factors such as the high healthcare spending, rising geriatric population, the rising prevalence of target diseases, growing number of cosmetic surgeries, ongoing research activities, and rapid adoption of technologically advanced imaging systems.
Buy Complete Assessment of Near Infrared Imaging/NIR market Now@ https://www.novaoneadvisor.com/report/checkout/4358
COVID-19 Impact on Near Infrared Imaging/NIR Sales
Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Near Infrared Imaging/NIR market.
Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Near Infrared Imaging/NIR market 2021 onwards. This trend will however continue through the course of the report’s assessment period
This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Near Infrared Imaging/NIR market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Some of the prominent players in the Near Infrared Imaging/NIR market include:
Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (US), Olympus Corporation (Japan), PerkinElmer, Inc. (US), LI-COR, Inc. (US), Medtronic (US), Hamamatsu Photonics K.K. (Japan), Shimadzu Corporation (Japan), Mizuho Medical Co., Ltd. (Japan), Fluoptics (France), Quest Medical Imaging B.V. (Netherlands), Sigma-Aldrich (Germany), and Teledyne Princeton Instruments (US), among others.
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
This research report categorizes the near-infrared imaging market based on product, application, procedure, end-user, and region
Based on the Product:
- Near-infrared fluorescene imaging systems
- Near-infrared fluorescene and bioluminescene imaging systems
- Small organic molecule based
- Nanoparticle based
Based on Application:
- Preclinical Imaging
- Clinical Imaging
- Medical Imaging
Based on Procedure:
- Cancer surgery
- Gastrointestinal surgery
- Cardiovascular surgery
- Plastic/Reconstructive surgery
- Brain tumor surgery
Based on End Users:
- Hospitals & clinics
- Pharmaceutical and biotechnology companies
- Research laboratories
Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/near-infrared-imaging-nir-market
Why Buy this Report?
The purpose of Nova one advisor’s Near Infrared Imaging/NIR market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/4358
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Call: +1 9197 992 333